Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

Intuitive, Complete Neural Control of Tablet Computers for Communication

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

People with brainstem stroke, advanced amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), or other disorders can become unable to move or speak despite being awake and alert. In this project, the investigators seek to further translate knowledge about interpreting brain signals related to movement, and to further develop an intracortical brain-computer interface (iBCI) that could restore rapid and intuitive use of communication apps on tablet computers by people with paralysis.

Who May Be Eligible (Plain English)

Who May Qualify: - Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders - Complete or incomplete tetraplegia (quadriplegia) - Must live within a three-hour drive of the Study site - Prior enrollment in BrainGate2 clinical trial (NCT00912041) Who Should NOT Join This Trial: - Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses - Chronic oral or intravenous steroids or immunosuppressive therapy - Other serious disease or disorder that could seriously affect ability to participate in the study (There are additional exclusion criteria) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders * Complete or incomplete tetraplegia (quadriplegia) * Must live within a three-hour drive of the Study site * Prior enrollment in BrainGate2 clinical trial (NCT00912041) Exclusion Criteria: * Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses * Chronic oral or intravenous steroids or immunosuppressive therapy * Other serious disease or disorder that could seriously affect ability to participate in the study (There are additional exclusion criteria)

Treatments Being Tested

DEVICE

BrainGate Neural Interface System

Placement of the BrainGate2 sensor(s) into arm-hand motor-related cortex.

Locations (1)

Masssachusetts General Hospital
Boston, Massachusetts, United States